Host-pathogen interactions in Multidrug-Resistant Tuberculosis
|
|
- Philomena Hodges
- 6 years ago
- Views:
Transcription
1 Host-pathogen interactions in Multidrug-Resistant Tuberculosis Study of the Molecular Epidemiology, Host Immune responses and Genome Based prediction and Early Identification of MDR-TB in High Tuberculosis Burden Settings MDR-TBNet Consortium
2 Oportunity Problem ERANET-LAC Determination
3
4
5 Contributing to the control of a problem that affects a large part of the world population, generating a positive impact on the population. Establish collaboration, scientific and technological exchange. Research and learning
6
7 Coordinator Our Research Consortium Centro de Investigaciones Tecnológicas, Biomédicas y Medioambientales, Peru IRCCS Ospedale San Raffaele, Italy Universidade Federal de Minas Gerais, Brazil Hospital Sant Joan de Déu, Spain Research Center Borstel, Germany BIOASTER, France
8 Network strengths IRCCS Ospedale San Raffaele (Milano, Italy) Research hospital in Molecular Medicine WHO Collaborating Centre in Tuberculosis Laboratory Strengthening WHO Supranational Reference Laboratory for TB Research Center Borstel (Borstel, Germany) National Mycobacterium Reference Laboratory WHO Supranational Reference Laboratory CITBM (Callao, Peru) First peruvian RDI oriented center of excellence Strong molecular epidemiology background Universidade Federal de Minas Gerais (Belo Horizonte, Brazil) Top10 university Latin America Molecular and gentyping reference Hospital Sant Joan de Déu (Barcelona, Spain) Europeanwide renknown research and technology facility Bioaster (Lyon, France) Technology Research Institute dedicated to infectious diseases and microbiology in health
9 Introduction High prevalence of MDR-TB in Peru and Brazil Conventional diagnostic methods are time consuming Limit knowledge of immune response to MDR-TB MDR-TB host pathogen interactions not well defined
10 Goal Early detection Host-pathogen factors in MDR-TB MDR-TB Prevention
11
12 Cohort study Molecular epidemiology study Enrolment patients = 24 TB-MDR (n = 5) TB Sensible (n = 10) Control (n = 9) MODS Culture Baciloscopy
13 Technological transference 2017 Nurse training in sample collection and patient enrolment at UNIDEC CITBM and Hospital Dos de Mayo. TB molecular typing, sequencing and data analysis. Molecular and Experimental Mycobacteriology Group. Forschungszentrum Borstel - Germany, June Mycobacterial small regulatory RNAs. Emerging Bacterial Pathogens Unit., S. Raffalele Scientific Institute. Milán Italy, May June Fellow research at CITBM.
14 First steps
15 Coordinator Coordinator oordinator Our team Moisés Paolo Miotto Daniella Huamán (OSR, Italy) Bartolomeu (CITBM, Perú) Daniella Bartholomeu (UFMG, Brazil) Moises Huaman; Leading Paolo Miotto, (IRCCS Daniella (Universidade Bartholomeu Federal de Huaman; Scientist Leading (CITBM, Peru) Paolo Ospedale Miotto, San (IRCCS Raffaele, Italy) (Universidade Daniella Minas Bartholomeu Gerais, Federal Brazil) de tist uaman; (CITBM, Leading Peru) Ospedale Paolo Miotto, San Raffaele, (IRCCS Italy) (Universidade Minas Gerais, Federal Brazil) de t (CITBM, Peru) Ospedale San Raffaele, Italy) Minas Gerais, Brazil) Laia Alsina (Hospital Sant Stefan Niemann (Research Joan de Déu, Spain) Center Borstel, Germany) sina (Hospital Sant Stefan Niemann (Research na de (Hospital Déu, Spain) Sant Stefan Center Niemann Borstel, (Research Germany) de Déu, Spain) Center Borstel, Germany) BIOASTER, France BIOASTER, France BIOASTER, France
What can be done against XDR-TB?
What can be done against XDR-TB? Dr Matteo Zignol Stop TB Dep. World Health Organization Geneva 16 th Swiss Symposium on tuberculosis Münchenwiler, 22 March 2007 XDR-TB Extensive Drug Resistance XDR =
More informationThe epidemiology of tuberculosis
The epidemiology of tuberculosis Tuberculosis Workshop Shanghai, 12-22 May 28 Philippe Glaziou World Health Organization Outline Epidemiology refresher Estimates of tuberculosis disease burden Notifications
More informationXDR and MDR TB Urgent Research Priorities. Gerald Friedland MD Yale School of Medicine Nelson R Mandela School of Medicine
XDR and MDR TB Urgent Research Priorities Gerald Friedland MD Yale School of Medicine Nelson R Mandela School of Medicine The Year of MDR XDR TB CDC, WHO report on global XDR TB XDR TB defined Global distribution
More informationTB e HIV nelle coorti
TB e HIV nelle coorti Antonella d Arminio Monforte Clinica di Malattie Infettive Dipartimento di Scienze della Salute Università degli Studi di Milano Presidio Ospedalero San Paolo, ASST Santi Paolo e
More informationBachelor s Degree in:
den tis try Bachelor s Degree in: Dentistry Exchange Universities in Dentristry Degree: North America: 1 agreement Central and South America: agreements Europe: 1 agreements Contact information: uic.es/contact-details
More informationXDR-TB Extensively Drug-Resistant Tuberculosis. What, Where, How and Action Steps
XDR-TB Extensively Drug-Resistant Tuberculosis What, Where, How and Action Steps The boundaries and names shown and the designations used on this map do not imply the expression of any opinion whatsoever
More information* WHO Collaborating Centre for TB and Lung Diseases, Fondazione S. Maugeri, Care and
ERJ Express. Published on August 9, 2007 as doi: 10.1183/09031936.00077307 RAPID PUBLICATION Clinical and operational value of the XDR-TB definition Giovanni Battista Migliori *, Giorgio Besozzi, Enrico
More informationFood, climate change and human health
Paolo Vineis Imperial College London and HuGeF Foundation Torino Food, climate change and human health Italian Embassy, London, 20 october 2014 Imperial College London The worrying situation of non-communicable
More informationDrug-resistant Tuberculosis
page 1/6 Scientific Facts on Drug-resistant Tuberculosis Source document: WHO (2008) Summary & Details: GreenFacts Context - Tuberculosis (TB) is an infectious disease that affects a growing number of
More informationSupplementary Appendix
Supplementary Appendix This appendix has been provided by the authors to give readers additional information about their work. Supplement to: Günther G, Lange C, Alexandru S, et al. Treatment outcomes
More informationGUIDELINES, STATEMENTS & STANDARDS ON TUBERCULOSIS [AS OF FEBRUARY 2005] PART I. GROUPED BY AGENCY/ORGANIZATION
GUIDELINES, STATEMENTS & STANDARDS ON TUBERCULOSIS [AS OF FEBRUARY 2005] PART I. GROUPED BY AGENCY/ORGANIZATION Agency/Organization Name of the Guide/Statement Available at World Health Organization 1
More informationThe Lancet Infectious Diseases
Xpert MTB/RIF Ultra for detection of Mycobacterium tuberculosis and rifampicin resistance: a prospective multicentre diagnostic accuracy study Susan E Dorman, Samuel G Schumacher, David Alland et al. 2017
More informationTB trends and TB genotyping
Management of a TB Contact Investigation for Public Health Workers Albuquerque, NM October 1, 214 TB trends and TB genotyping Marcos Burgos MD October 1, 214 Marcos Burgos, MD has the following disclosures
More informationHow Is TB Transmitted? Sébastien Gagneux, PhD 20 th March, 2008
How Is TB Transmitted? Sébastien Gagneux, PhD 20 th March, 2008 Today s Outline 1) Global spread of Mtb Comparative genomics Phylogeny 2) Transmission of drug-resistant Mtb Fitness assays Molecular epidemiology
More informationTask Force Members: Mandy Lauw, Chairman Geoff Barnes, Immediate Past Chairman
Task Force Members: Mandy Lauw, Chairman Mandy Lauw (30, The Netherlands) is a Research Fellow at the Departments of Vascular Medicine and Hematology, Academic Medical Center, Amsterdam, The Netherlands,
More informationCall to Action To Accelerate Access to DR-TB Drugs: 2016 Update
Call to Action To Accelerate Access to DR-TB Drugs: 2016 Update June 3, 2016 On March 10 th, 2015, Médecins Sans Frontières (MSF), ACTION Global Health Advocacy Partnership, SWIFT Response Project, Treatment
More informationExperts Consultation Development of a Protocol for Epidemiological Investigations in Recreational Bathing Waters
WHO Guidelines for Safe Recreational Water Environments Experts Consultation Development of a Protocol for Epidemiological Investigations in Recreational Bathing Waters Mexico City, Mexico, Gerencia de
More informationIARC A UNIQUE AGENCY. Cancer research for cancer prevention
IARC A UNIQUE AGENCY Cancer research for cancer prevention Director s message IARC is a unique organization. For the past 50 years, the Agency has been making important contributions to the global fight
More informationXDR TUBERCULOSIS IN EUROPE EPIDEMIOLOGICAL ASPECTS. Enrico Girardi Unità di Epidemiologia Clinica INMI Spallanzani, Roma. Pag. 1
XDR TUBERCULOSIS IN EUROPE EPIDEMIOLOGICAL ASPECTS Enrico Girardi Unità di Epidemiologia Clinica INMI Spallanzani, Roma Pag. 1 TB estimated incidence in EUR, 2004 Russian Fed. 12 th among the 22 TB high-burden
More informationIntroduction. Cahn et al. Andean Pacific HIV Clinical Forum 2017; Santiago, Chile. Abstract 2.
Efficacy of Dolutegravir/Abacavir/Lamivudine (DTG/ABC/3TC) Fixed Dose Combination (FDC) Compared With Ritonavir- Boosted Atazanavir (ATV/r) Plus Tenofovir Disoproxil Fumarate/Emtricitabine (TDF/FTC) in
More informationMarch 24, 2007 will mark the 125th anniversary of Robert
Eur Respir J 2007; 29: 423 427 DOI: 10.1183/09031936.00001307 CopyrightßERS Journals Ltd 2007 EDITORIAL 125 years after Robert Koch s discovery of the tubercle bacillus: the new XDR-TB threat. Is science
More informationSupplementary appendix
Supplementary appendix This appendix formed part of the original submission and has been peer reviewed. We post it as supplied by the authors. Supplement to: Dorman S E, Schumacher S G, Alland D, et al.
More information2010 global TB trends, goals How DOTS happens at country level - an exercise New strategies to address impediments Local challenges
Outline of what it will take Tuberculosis Elimination 25: Global and Local Challenges Anne Fanning, MD November 9, 211 21 global TB trends, goals How DOTS happens at country level - an exercise New strategies
More informationICQC Scientific Consensus on Whole Grains (Sept 29 th, 2017) Introduction: The quality of carbohydrates (dietary fiber, whole grains, glycemic index
ICQC Scientific Consensus on Whole Grains (Sept 29 th, 2017) Introduction: The quality of carbohydrates (dietary fiber, whole grains, glycemic index and load) matters greatly to health and disease. In
More informationNetworks of Cognition, People and Computers against Alzheimer s disease: an Italian idea from European to Regional scale (DECIDE)
Networks of Cognition, People and Computers against Alzheimer s disease: an Italian idea from European to Regional scale (DECIDE) Claudio Babiloni on behalf of DECIDE Consortium IRCCS San Raffaele Pisana,
More informationMolecular typing for surveillance of multidrug-resistant tuberculosis in the EU/EEA
SURVEILLANCE REPORT Molecular typing for surveillance of multidrug-resistant tuberculosis in the EU/EEA March 2017 Summary This report describes the geographical and temporal distribution of multidrug-resistant
More informationEuropean Guide on Quality Improvement in Comprehensive Cancer Control
European Guide on Quality Improvement in Comprehensive Cancer Control 13 March 2013, JRC, Ispra Presentation prepared by the National Institute of Public Health of Slovenia OBJECTIVES 1) To identify key
More informationTNT Session. The latest clinical evidence in diabetics for the Amphilimus TM eluting polymer-free DES. Rafael Romaguera, MD
TNT Session The latest clinical evidence in diabetics for the Amphilimus TM eluting polymer-free DES Rafael Romaguera, MD Hospital de Bellvitge Barcelona Spain Disclosure Statement of Financial Interest
More informationTable Of Content. Outputs... 8
Table Of Content European Network of Reference for Rare Pediatric Neurological Diseases... 2 Summary... 3 Coordinator, Leader contact and partners... 5 University College London... 5 Univerzita Karlova
More informationRevitalising community engagement for TB and TB/HIV prevention, diagnosis and treatment
17 th TB/HIV Core Group meeting, Beijing, China. November 11, 2011 Revitalising community engagement for TB and TB/HIV prevention, diagnosis and treatment Haileyesus Getahun Stop TB Department WHO Outline
More informationThe Experience of the Telehealth Network of Minas Gerais, Brazil
The Experience of the Telehealth Network of Minas Gerais, Brazil Maria Beatriz Alkmim 1, Renato Figueira 1, Lidiane Souza 1, Milena Marcolino 1,2, Cristiane Pessoa 1, Daniel Neves 1, Antonio Luiz Ribeiro
More information3.1 PHASE 2 OF THE GLOBAL PROJECT
RESULTS CHAPTER 3 3.1 PHASE 2 OF THE GLOBAL PROJECT (1996 1999) This new report of the Global Project provides data on anti-tuberculosis drug resistance from 58 geographical settings. Of these, 28 provided
More informationTB Infection Control Policy. Scaling-up the implementation of collaborative TB/HIV activities in the Region of the
TB Infection Control Policy Scaling-up the implementation of collaborative TB/HIV activities in the Region of the Infection Control is aimed at minimizing the risk of TB transmission within populations
More informationMultidrug-Resistant TB
Multidrug-Resistant TB Diagnosis Treatment Linking Diagnosis and Treatment Charles L. Daley, M.D. National Jewish Health University of Colorado Denver Disclosures Chair, Data Monitoring Committee for delamanid
More informationGlobal Perspective on Transmission: Value in Genotype Mapping of Disease Transmission Dynamics
Global Perspective on Transmission: Value in Genotype Mapping of Disease Transmission Dynamics Neel R. Gandhi, MD Emory Rollins School of Public Health January 17, 2013 Medical Research Council BMJ 1948
More informationLa Lotta alla Tubercolosi. Matteo Zignol and Mario C. Raviglione Stop TB Department WHO, Geneva, Switzerland. Geneva March 2012
La Lotta alla Tubercolosi Matteo Zignol and Mario C. Raviglione Stop TB Department WHO, Geneva, Switzerland Geneva 19-20 March 2012 Overview of the presentation The global burden of tuberculosis The WHO
More informationThe WHO Global Project on anti-tb drug resistance surveillance: background, objectives, achievements, challenges, next steps
The WHO Global Project on anti-tb drug resistance surveillance: background, objectives, achievements, challenges, next steps Matteo Zignol STOP TB Department World Health Organization TB surveillance and
More informationMolecular tests for rapid detection of rifampicin and isoniazid resistance in Mycobacterium tuberculosis.
Title Molecular tests for rapid detection of rifampicin and isoniazid resistance in Mycobacterium. Author(s) Ho, PL; Yam, WC; Leung, CC; Yew, WW; Mok, TYW; Chan, KS; Tam, CM Citation Hong Kong Medical
More informationAPHL Next Generation Sequencing (NGS) Survey
Next Generation Sequencing 1. How long has your lab had a sequencer? [If lab does not have a sequencer go to 1a1 through 1a3 and then end survey] [If lab does have a sequencer continue to 1a and the rest
More informationMarc Moss, MD President, American Thoracic Society (202) th St, N.W. #300 Washington, DC 20036
Marc Moss, MD President, American Thoracic Society Nmoore@thoracic.org; (202) 296. 9770 1150 18 th St, N.W. #300 Washington, DC 20036 STATEMENT OF THE AMERICAN THORACIC SOCIETY SUBMITTED TO THE HOUSE LABOR,
More informationContact Tracing and Active Case Finding: Underused Tools to Reduce the Burden of TB in Children
Contact Tracing and Active Case Finding: Underused Tools to Reduce the Burden of TB in Children Regional TB Symposium Dushanbe, Tajikistan 2013 Dr Clara van Gulik Paediatric TB and HIV advisor Medecins
More information2. Treatment coverage: 3. Quality of care: 1. Access to diagnostic services:
The theme for World TB Day 2014 is Reach the missed 3 million. Every year 3 million people who fall ill with TB are missed by health systems and do not always get the TB services that they need and deserve.
More informationDiabetic Eye Care; Workforce Challenges and opportunities
Diabetic Eye Care; Workforce Challenges and opportunities Hugh R. Taylor, AC, MD April 2013 Bangkok How many ophthalmologists in practice and training worldwide? Study designed and conducted by ICO in
More informationAbstract. Introduction. Editor: M. Drancourt
ORIGINAL ARTICLE BACTERIOLOGY Validation of microscopic observation drug susceptibility testing for rapid, direct rifampicin and isoniazid drug susceptibility testing in patients receiving tuberculosis
More informationstudies would be large enough to have the power to correctly assess the joint effect of multiple risk factors.
Collaborative Research: examples of multicentre studies The need for an organization with a worldwide mandate to promote and lead international collaborations in cancer research was one of the main driving
More informationGUIDELINES, STATEMENTS & STANDARDS ON TUBERCULOSIS [AS OF NOVEMBER 2004] PART I. GROUPED BY AGENCY/ORGANIZATION
GUIDELINES, STATEMENTS & STANDARDS ON TUBERCULOSIS [AS OF NOVEMBER 2004] PART I. GROUPED BY AGENCY/ORGANIZATION Agency/Organization Name of the Guide/Statement Available at World Health Organization 1
More informationEpidemiology and clinical management of XDR-TB: a systematic review by TBNET
Eur Respir J 2009; 33: 871 881 DOI: 10.1183/09031936.00168008 CopyrightßERS Journals Ltd 2009 REVIEW Epidemiology and clinical management of XDR-TB: a systematic review by TBNET G. Sotgiu, G. Ferrara,
More informationTransmissibility, virulence and fitness of resistant strains of M. tuberculosis. CHIANG Chen-Yuan MD, MPH, DrPhilos
Transmissibility, virulence and fitness of resistant strains of M. tuberculosis CHIANG Chen-Yuan MD, MPH, DrPhilos Transmissibility, Virulence and Fitness of resistant strains of M. tuberculosis For infectious
More informationGeographical distribution and clinical relevance of nontuberculous mycobacteria in Croatia
Geographical distribution and clinical relevance of nontuberculous mycobacteria in Croatia M. Jankovic 1, M. Samarzija 1, I. Sabol 2, M. Jakopovic 1, V. Katalinic Jankovic 3, LJ. Zmak 3, B. Ticac 4, A.
More informationIndications for catheter ablation in 2010: Ventricular Tachycardia
Indications for catheter ablation in 2010: Ventricular Tachycardia Paolo Della Bella, MD Arrhythmia Department and Clinical Electrophysiology Laboratories Ospedale San Raffaele, IRCCS, Milan, Italy Europace
More informationBrazilian Academic Consortium for Integrative Health. Ricardo Ghelman, MD, PhD Chair
Brazilian Academic Consortium for Integrative Health Ricardo Ghelman, MD, PhD Chair Following the WHO guidelines for the construction of qualified knowledge and scientific evidence on TCIM; The necessity
More informationTUBERCULOSIS AND HIV/AIDS: A STRATEGY FOR THE CONTROL OF A DUAL EPIDEMIC IN THE WHO AFRICAN REGION. Report of the Regional Director.
30 August 2007 REGIONAL COMMITTEE FOR AFRICA ORIGINAL: ENGLISH Fifty-seventh session Brazzaville, Republic of Congo, 27 31 August Provisional agenda item 7.8 TUBERCULOSIS AND HIV/AIDS: A STRATEGY FOR THE
More informationWelcome to. The Fundamentals of International Clinical Research Workshop. Stevenson, Washington
Welcome to The Fundamentals of International Stevenson, Washington Robin M. Mason, MS, MBA Division of Microbiology and Infectious Diseases of Allergy and Infectious Diseases NIH, DHHS Fundamentals of
More informationThe diagnostic value of gyrb RFLP PCR. Mycobacteria in patients with clinical. in Mazandaran
Mazandaran University of Medical Sciences The diagnostic value of gyrb RFLP PCR test t in differentiation between pathogenic Mycobacteria in patients with clinical suspicions spicions of tuberculosis in
More informationOSU SLEEP MEDICINE PROGRAM at WEXNER MEDICAL CENTER
OSU SLEEP MEDICINE PROGRAM at WEXNER MEDICAL CENTER Ulysses J. Magalang, MD Professor of Medicine and Neuroscience Division of Pulmonary, Allergy, Critical Care, and Sleep Medicine Director, Sleep Disorders
More informationImplementation of myocardial system of care in a rural area in Brazil using telecardiology
Implementation of myocardial system of care in a rural area in Brazil using telecardiology Prof. Antonio Luiz Pinho Ribeiro Research and Innovation Head, University Hospital Universidade Federal de Minas
More informationTuberculosis Now! Jon S Friedland MA, FRCPE, FMedSci. Infectious Diseases & Immunity
Tuberculosis Now! Jon S Friedland MA, FRCPE, FMedSci Infectious Diseases & Immunity What is TB Now? Epidemiology including international migration Biomarkers New treatments TB notification rate per 1
More informationA UNIQUE NETWORK OF EXPERTISE DEDICATED TO THE FIGHT AGAINST INFECTIOUS DISEASES
A UNIQUE NETWORK OF EXPERTISE DEDICATED TO THE FIGHT AGAINST INFECTIOUS DISEASES Since 1888, date of its creation, has been committed to contain infectious diseases by working directly in regions where
More informationStop TB Working Group on DOTS-Plus for MDR-TB Strategic Plan
Stop TB Working Group on DOTS-Plus for MDR-TB Strategic Plan 2006-2015 Background Current threat and status of the global epidemic of multidrug resistant tuberculosis (MDR-TB) Along with HIV/AIDS, MDR-TB
More informationFondation Mérieux Mission and Activities
Fondation Mérieux Mission and Activities Testes de Diagnóstico in Vitro Acessíveis e com Qualidade Assegurada para Programas de Saúde Pública Brazil April 2012 JF de Lavison MISSION Strengthen local capacities
More informationGLOBAL ANTIMICROBIAL RESISTANCE SURVEILLANCE
GLOBAL ANTIMICROBIAL RESISTANCE SURVEILLANCE Sonja Löfmark Public Health Agency of Sweden 6 th BARN Workshop May 12, 2016 Uppsala What is GLASS? A global programme for AMR surveillance The data it collects
More information12/10/2018. Agenda. Screening for Latent TB among Migrants in Italy. Agenda. Conflict of interest. LTBI definition from a pragmatic point of view
Screening for Latent TB among Migrants in 1. The rationale for to screening for latent TB in migrants Delia Goletti, Alberto Matteelli, Daniela Cirillo National Institute for Infectious Diseases L. Spallanzani,
More informationApproach to the Ethical Review
Harlan Laboratories Approach to the Ethical Review Contract Research Services Markus Josten 04-May-2009 Who are we? Well known for our research models, diets, bedding and research model services, with
More informationUpdate on the Global Use of Bedaquiline and Delamanid for Programmatic Management of Drug- Resistant Tuberculosis
Update on the Global Use of Bedaquiline and Delamanid for Programmatic Management of Drug- Resistant Tuberculosis DR-TB Scale-Up Treatment Action Team (DR-TB STAT) October 2017 Content What is DR-TB STAT?
More informationPortinari: A Data Exploration Tool to Personalize Cervical Cancer Screening
Portinari: A Data Exploration Tool to Personalize Cervical Cancer Screening Sagar Sen, Manoel Horta Ribeiro, Raquel C. de Melo Minardi, Wagner Meira Jr., Mari Nygård Certus V&V Center and HPV Research
More informationDrug-resistant Tuberculosis
page 1/15 Scientific Facts on Drug-resistant Tuberculosis Source document: WHO (2008) Summary & Details: GreenFacts Level 2 - Details on Drug-resistant Tuberculosis 1. What is tuberculosis and why is it
More informationPublic Health Programme : Information Day Work shop: Health Threats
Public Health Programme 2003-2008: Information Day Work shop: Health Threats Luxembourg 3 February 2005, Jean Monnet Building Rue Alcide de Gasperi, L-2920 Luxembourg room M3 A. Werner, MD, Priv. Doz.
More informationPost-2015 TB Elimination Strategy and Targets
Photo: Riccardo Venturi Vision and proposed framework for a Post-2015 TB Elimination Strategy and Targets Consultation on Eliminating the catastrophic economic burden of TB" Universal Health Coverage and
More informationCenters for Disease Control and Prevention (CDC) FY 2009 Budget Request Summary
Centers for Disease Control and Prevention (CDC) FY 2009 Budget Request Summary The President s FY 2009 Budget Request for the Centers for Disease Control and Prevention (CDC) discretionary funding is
More informationHealth for Humanity 2020 Goals 2
2017 for Humanity Report Better for Humanity 2020 s 2 At Johnson & Johnson, we aspire to profoundly change the trajectory of health for humanity. Our for Humanity 2020 s, underpinned by 16 targets, focus
More informationModern TB Diagnostic Services: Optimizing the Old with the New
Modern TB Diagnostic Services: Optimizing the Old with the New 6 th Global Laboratory Initiative (GLI) Partners Meeting incorporating Global consultation of the TB SRL Network Global Forum of Xpert MTB/RIF
More informationOnline Annexes (2-4)
Online Annexes (2-4) to WHO Policy update: The use of molecular line probe assays for the detection of resistance to isoniazid and rifampicin THE END TB STRATEGY Online Annexes (2-4) to WHO Policy update:
More informationEvaluation of the Microscopic-Observation. Drug-Susceptibility Assay Drugs Concentration for Detection Of Multidrug-Resistant Tuberculosis
Evaluation of the Microscopic-Observation Drug-Susceptibility Assay Drugs Concentration for Detection Of Multidrug-Resistant Tuberculosis ABSTRACT New diagnostic tools are urgently needed to interrupt
More informationMedia centre Global infectious disease surveillance
Media centre Global infectious disease surveillance Fact sheet N 200 Increased movements of people, expansion of international trade in foodstuffs and medicinal biological products, social and environmental
More informationDrug resistance TB in People Living with HIV: research questions and priorities.
Drug resistance TB in People Living with HIV: research questions and priorities. Haileyesus Getahun, MD, PhD. Stop TB Department World Health Organisation Geneva, Switzerland Outline of presentation Definition
More informationAnnexes to Chapter: Tuberculosis
Annexes to Chapter: Tuberculosis Annex 1a: TB burdens in the expanded European Union (Statistics prepared by Dr W Kaplan, Essential Drugs and Medicines Policy, WHO, Feb 2004) Total TB Burden (2001) Poland
More informationFiocruz the National Contact Point in Health
Fiocruz the National Contact Point in Health Fundação Oswaldo Cruz FIOCRUZ Research Education Innovation and Production Surveillance and Reference Services Health & Medical Care Environment and Health
More informationMeta-Analyses of Epigenetics Risk Factors for Cardiovascular Health: APOA5 Human Gene Variations Across Different Race-Ethnicity Groups
Meta-Analyses of Epigenetics Risk Factors for Cardiovascular Health: APOA5 Human Gene Variations Across Different Race-Ethnicity Groups Yen-Chun Lin, PhD, RN, National Taiwan University Veronica Nunez,
More informationTHE ULTIMATE EVOLUTION IN DES TECHNOLOGY FOR DIABETICS: CRE8 EVO
The ultimate EVOlution in DES technology for diabetics: Cre8 EVO THE ULTIMATE EVOLUTION IN DES TECHNOLOGY FOR DIABETICS: CRE8 EVO Rafael Romaguera, MD Barcelona Spain Rafael Romaguera, MD Hospital de Bellvitge
More informationECTRIMS-MAGNIMS MAGNETIC RESONANCE IMAGING IN MULTIPLE SCLEROSIS FELLOWS Awardees
ECTRIMS-MAGNIMS MAGNETIC RESONANCE IMAGING IN MULTIPLE SCLEROSIS FELLOWS 2017 Awardees Soheil Damangir, PhD Optimizing crowd-sourced solutions toward generating large reference datasets for WM lesion segmentation
More informationDiagnosis of TB in Belarus, statistics and challenges of establishing an accurate and timely DR-TB diagnosis in high MDR-TB prevalence settings
Tuberculosis in 2017: Searching for new solutions in the face of new challenges 6th TB Symposium Ministry of Health of the Republic of Belarus, Republican Scientific and Practical Center for Pulmonology
More informationEPAG UPDATE. Lenja Wiehe. European Patient Advocacy Groups Manager, EURORDIS
EPAG UPDATE Lenja Wiehe European Patient Advocacy Groups Manager, EURORDIS Patient Centre & Empowerment European Reference Networks (ERNs) created on founding principles of patient-centred care, patient
More informationReady for a CRO That Values Performance Over Promises? CHALLENGE. At Clinipace, it s personal.
Ready for a CRO That Values Performance Over Promises? CHALLENGE At Clinipace, it s personal. Who We Are At Clinipace, It s Personal. We Will PROVE IT. With us, you get the A team. We deliver a level of
More informationChapter 1 Overview of Tuberculosis Epidemiology in the United States
Chapter 1 Overview of Tuberculosis Epidemiology in the United States Table of Contents Chapter Objectives.... 1 Progress Toward TB Elimination in the United States... 3 TB Disease Trends in the United
More informationPico s Adventure. with Autism through Full-Body Interaction Prof. Narcís Parés Cognitive Media Technologies Group - DTIC
Pico s Adventure Interactive Communication to foster Social Initiation in Children with Autism through Full-Body Interaction Prof. Narcís Parés Cognitive Media Technologies Group - DTIC Outline Introduction
More informationMolecular typing for surveillance of multidrug-resistant tuberculosis in the EU/EEA
Molecular typing for surveillance of multidrug-resistant tuberculosis in the EU/EEA January 2016 Summary This report describes the geographical and temporal distribution of multidrug-resistant (MDR) tuberculosis
More informationGlobal TB Burden, 2016 estimates
TUBERCULOSIS EPIDEMIOLOGY LOCAL, STATE, NATIONAL, GLOBAL Office of Communicable Disease Epidemiology Global TB Burden, 216 estimates Total TB Estimated number of TB cases 1.4 million 14 per 1, Estimated
More informationAnnual Epidemiological Report
July 2018 Annual Epidemiological Report 1 Legionellosis in Ireland, 2017 Key Facts There were 25 cases of Legionnaires disease notified in Ireland in 2017 The rate per million population increased from
More informationINTEGRATION OF PREVENTION AND CONTROL OF NONCOMMUNICABLE DISEASES AND TUBERCULOSIS: A CASE FOR ACTION
INTEGRATION OF PREVENTION AND CONTROL OF NONCOMMUNICABLE DISEASES AND TUBERCULOSIS: A CASE FOR ACTION Global commitments to prevent and control noncommunicable diseases and to end the global tuberculosis
More informationOverview of the TB epidemic globally and in India
Overview of the TB epidemic globally and in India Dr Soumya Swaminathan Deputy Director General for Programmes 5 th GLOBAL FORUM ON TB VACCINES PARTNERING FOR PROGRESS AND INNOVATION February 20, 2018
More informationOngoing Research on LTBI and Research priorities in India
Ongoing Research on LTBI and Research priorities in India Dr. C.Padmapriyadarsini, MD, MS ICMR-National Institute for Research in Tuberculosis Chennai, India Technical Consultation Meeting on Programmatic
More informationDANISH GUIDELINES FOR PREVENTION AND TREATMENT OF TB IN CHILDREN
DANISH GUIDELINES FOR PREVENTION AND TREATMENT OF TB IN CHILDREN Troels Lillebæk Director, Consultant, DMSc, DTM&H International Reference Laboratory of Mycobacteriology / WHO TB Supranational Reference
More informationOsaka City is the third largest city (population
Surveillance Report Strengthened tuberculosis control programme and trend of multidrug resistant tuberculosis rate in Osaka City, Japan Akira Shimouchi, a Akihiro Ohkado, a Kenji Matsumoto, b Jun Komukai,
More informationEBMT Society EBMT. History Organisation Studies Activity Philosophy. EBMT Website. European Group for Blood and Marrow Transplantation
EBMT EBMT Organisation and Activities J Apperley 13th. ESH-EBMT Training Course Targu Mures May 24 26, 2010 History Organisation Studies Activity Philosophy EBMT Website www.ebmt.org EBMT Society European
More informationGenotyping analyses of tuberculosis transmission among immigrant residents in Italy
ORIGINAL ARTICLE BACTERIOLOGY Genotyping analyses of tuberculosis transmission among immigrant residents in Italy F. Franzetti 1, L. Codecasa 2, A. Matteelli 3, A. Degli Esposti 1, A. Bandera 1, C. Lacchini
More informationDrug Resistant Tuberculosis Biology, Epidemiology and Control Dr. Christopher Dye
Director of Health Information World Health Organization Geneva 1 1. Why TB patients are treated with drugs 2 Natural history and control of TB Fast 5/1 Slow 5/1 Uninfected Latent Active 1 1 infection/case
More information9th INTERNATIONAL NICE September, 2018 Milan, Italy. Islet - beta cell. replacement
9th INTERNATIONAL 24-26 September, 2018 Milan, Italy 9th INTERNATIONAL AIM OF THE MEETING The aim of this workshop is to provide theoretical education and practical training to scientists, physicians,
More informationDiagnosis of TB in Vaccine Trials. Marcel A. Behr McGill University, Montreal
Diagnosis of TB in Vaccine Trials Marcel A. Behr McGill University, Montreal marcel.behr@mcgill.ca Overview Background / Declarations Previous work, inferences Current interpretations Future considerations
More informationIntroduction and illustration of the OECI study proposal/feedback of the survey on outcome studies Milena Sant, MD
Introduction and illustration of the OECI study proposal/feedback of the survey on outcome studies Milena Sant, MD Analytical Epidemiology and Health Impact Unit Department of Preventive and Predictive
More informationTB Epidemiology. Richard E. Chaisson, MD Johns Hopkins University Center for Tuberculosis Research
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike License. Your use of this material constitutes acceptance of that license and the conditions of use of materials on this
More information